hiPSC-derived Microglia Culture and Isolation Service
Microglia are the resident immune cells of the central nervous system (CNS). They play crucial roles in immune surveillance, responding to injury and pathogens, synaptic pruning, and neuronal support and protection. Dysfunctional microglial responses have been implicated in many neurological and neurodegenerative diseases.
Microglia can be derived from induced pluripotent stem cells (iPSCs) through specific differentiation protocols. iPSCs are stem cells reprogrammed from somatic cells like skin or blood cells back into a pluripotent state. The iPSCs can then be directed to become microglial progenitor cells that mature into functional microglia-like cells. Creative Biolabs offers custom services to generate iPSC-derived microglia for research applications.
Key Advantages of iPSC-derived Microglia Include
|
|
|
|
|
Applications of hiPSC-derived Microglia in Research
|
|
|
|
Common Assays Utilize hiPSC-derived Microglia
- Phagocytosis and oxidative stress functional assays
Assessing microglial phagocytic activity and production of reactive oxygen species which can damage neurons.
- Co-cultures with hiPSC-derived neurons/astrocytes
Modeling interactions between microglia and other neural cell types by co-culturing in 2D/3D systems.
- Inflammatory response/cytokine profiling assays
Quantifying secretion of pro-inflammatory cytokines like TNF-α, and IL-1β in response to immune challenges.
- Compound screening for anti-inflammatory/neuroprotective effects
High-throughput screens to identify compounds that modulate microglial activation and improve neuronal survival.
- RNA-sequencing and microglial signature analysis
Transcriptomic profiling to define gene expression patterns associated with different microglial activation states.
Microglial Dysfunction Has Been Linked To
- Alzheimer's disease: Microglia implicated in amyloid-beta clearance
Microglia normally clear amyloid-beta plaques, but this function becomes impaired in Alzheimer's, exacerbating the disease.
- Parkinson's disease: Neuroinflammation and oxidative stress
Overactive microglia induces oxidative stress and neuroinflammation that damages dopaminergic neurons in Parkinson's.
- Multiple sclerosis: Microglial activation and CNS inflammation
In MS, aberrant microglial activation contributes to damaging CNS inflammation and demyelination of neurons.
- Stroke: Microglia mediate post-ischemic neuroinflammation
After ischemic stroke injury, microglia become over-activated, causing oxidative damage and impairing neuronal recovery.
- Autism spectrum disorders: Altered synaptic pruning
Microglia regulate synaptic pruning during development, and impairments may contribute to autism phenotypes.
hiPSC models allow studying patient microglia harboring disease-relevant genetic backgrounds. Researchers can investigate aberrant microglial responses, evaluate new therapeutics targeting microglia, and explore cell therapy approaches using hiPSC-derived microglia.
In summary, hiPSC-derived microglia serve as a powerful platform for studying microglial biology, and neuroinflammation and developing new therapies for various neurological conditions involving microglial dysfunction. Creative Biolabs provides hiPSC-derived microglia designed to meet the specific requirements of your project's research needs. Let us guide you through your experimental investigations and help advance your understanding of neuroinflammation.
Reference
- Badanjak, Katja et al. "iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson's Disease." Front Cell Dev Biol. 2021;9:740758. Distributed under Open Access license CC BY 4.0. The original image was modified.
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- NeuroMab™ Anti-FGFR1 Antibody(NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- NeuroMab™ Anti-TREM2 Antibody(NRP-0422-P792) (Cat#: NRP-0422-P792)
- NeuroMab™ Anti-Alpha Synuclein Antibody(NRP-0422-P614) (Cat#: NRP-0422-P614)
- NeuroMab™ Anti-Tau Antibody(NRP-0422-P1684) (Cat#: NRP-0422-P1684)
- NeuroMab™ Anti-Integrin αvβ8 BBB Shuttle Antibody(NRZP-1222-ZP1218) (Cat#: NRZP-1222-ZP1218)
- NeuroMab™ Anti-pTau Antibody(NRP-0422-P1719) (Cat#: NRP-0422-P1719)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Green Fluorescent Alpha-synuclein SH-SY5Y Cell Line (Cat#: NCL2110P209)
- Human Blood Brain Barrier Model (Cat#: NCL-2103-P187)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Mouse Retinal Ganglion Cells (Cat#: NCL2110P145)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- iNeu™ Human Neural Stem Cell Line (Cat#: NCL200552ZP)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- rAAV-E-SARE-Cre-ERT2-PEST-WPRE-hGH polyA (Cat#: NTA-2010-TT342)
- pAAV-syn-jGCaMP8s-WPRE (Cat#: NTA-2106-P063)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- pAAV-syn-jGCaMP8m-WPRE (Cat#: NTA-2106-P062)
- Dextran, NHS Activated, 40 kDa (Cat#: NRZP-0722-ZP124)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran-FITC (Cat#: NTA-2011-ZP110)
- pAAV-hSyn-DIO-XCaMP-R-WPRE (Cat#: NTA-2012AD-P508)
- pAAV-syn-FLEX-jGCaMP8s-WPRE (Cat#: NTA-2106-P066)
- pAAV-syn-FLEX-jGCaMP8m-WPRE (Cat#: NTA-2106-P065)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)